Streetbeat News

Stock Prices

SENS

Senseonics Holdings, Inc. has announced a $16 million registered direct offering, involving the purchase and sale of 45,714,286 shares at $0.35 per share.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:03 pm

AQST

Aquestive Therapeutics will present an analysis of their Anaphylm sublingual epinephrine film at the ACAAI 2024. The data shows that the film has consistent pharmacokinetics (PK) and pharmacodynamics (PD) comparable to injections, regardless of placement or movement.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:03 pm

ENGN

enGene Holdings Inc. (NASDAQ:ENGN) has announced a private placement of 6,758,311 common shares at $8.90 per share, expecting to raise approximately $60 million. The financing is set to close on October 29, 2024, with participation from several investment firms.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:03 pm

IDYA

IDEAYA Biosciences shares rose following the announcement of positive Phase 1 expansion data for IDE397 in specific cancer patients, presented at a major symposium.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:02 pm

TNET

Trinet Group reported its Q3 2024 financial results, with adjusted EPS of $1.17 missing the estimate of $1.31, and sales of $1.237 billion falling short of the $1.242 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:01 pm

SKX

Skechers USA shares rose following the release of strong Q3 financial results. The company exceeded expectations and increased its FY23 EPS and FY24 revenue guidance, with the latter's midpoint surpassing estimates.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:01 pm

FHB

First Hawaiian (NASDAQ:FHB) reported Q3 2024 earnings per share of $0.48, surpassing the analyst estimate of $0.44. The company's sales were $209.995 million, exceeding the expected $205.226 million and marking a 3.32% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:01 pm

OLN

Olin Corporation's shares are declining following the release of mixed Q3 financial results and the announcement that Hurricane Beryl will affect its chemical businesses.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:01 pm

HALO

Halozyme Therapeutics (NASDAQ:HALO) has been analyzed by 12 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $62.5, up from $60.92. The company has strong financial metrics but faces high debt levels.

Portfolio Pulse from Benzinga Insights

October 25, 2024 | 12:01 pm

MGRC

McGrath RentCorp shares rose following the announcement of better-than-expected Q3 sales results.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:00 pm